A Chronic Arterial Cannula for Blood Sampling in Conscious, Unrestrained Rats.

Contemp Top Lab Anim Sci

Sector of Operational Medicine Research, Defence and Civil Institute of Environmental Medicine, 1133 Sheppard Ave. West, Toronto, Ontario, Canada M3M 3B9.

Published: September 1998

We require repeated blood samples for at least 10 days from conscious, unrestrained rats in our studies investigating the inflammatory response to intra-abdominal infection. Furthermore, we require a means by which other experimental devices (implanted concurrently) can be kept out of reach of the animals for the duration of the study. Under these conditions, previously reported postoperative restraint and cannulation techniques did not allow cannula patency for longer than a few days. We designed a cannula that is constructed from microbore tubing, attached to a modified winged infusion catheter, and sutured over the scapulae of the animal. Our device features a curved, perforated tip to allow its easy insertion into the thoracic aorta via the left carotid artery, and it provides an attachment site for a small, lightweight backpack. This cannula has a small dead-space and accommodates repeated arterial blood sampling for at least 10 days without leading to bacteremia or significant alterations in hematological or immune parameters. With minor modifications, this cannula has potential application in the chronic cannulation of other vessels and ducts in other small animals.

Download full-text PDF

Source

Publication Analysis

Top Keywords

blood sampling
8
conscious unrestrained
8
unrestrained rats
8
cannula
5
chronic arterial
4
arterial cannula
4
cannula blood
4
sampling conscious
4
rats require
4
require repeated
4

Similar Publications

Background: Adrenal Vein Sampling (AVS) is the gold standard for categorizing primary aldosteronism (PA). However, catheterization of the right adrenal vein (RAV) can be technically challenging. This study aimed to investigate the validity of the right renal vertebral contour as fluoroscopic landmarks to help RAV orifice localization during AVS.

View Article and Find Full Text PDF

Oxycodone for analgesia in children undergoing endoscopic retrograde cholangiopancreatography: a randomized, double-blind, parallel study.

Front Pharmacol

January 2025

Department of Anesthesiology and Pediatric Clinical Pharmacology Laboratory, Shanghai Children's Medical Center, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Background: Postoperative visceral pain is a common complication after endoscopic retrograde cholangiopancreatography (ERCP). In this study, we compared the analgesic and anti-inflammatory effects of oxycodone and fentanyl in children undergoing ERCP.

Methods: A single-center, randomized, double-blind study was conducted at a tertiary care hospital affiliated with Shanghai Jiao Tong University.

View Article and Find Full Text PDF

Background: Microcirculation is the essential link between macrocirculation and cellular metabolism.

Objectives: To test our hypotheses that microcirculation variables will show a heterogeneous flow pattern during experimental endotoxaemia, and that fluid therapy and noradrenaline (NA) infusion will normalise altered microcirculation variables.

Study Design: In vivo experiments.

View Article and Find Full Text PDF

Objective: To observe how cognitive behavioral intervention affects physical symptoms, B-type Natriuretic Peptide (BNP), Red Cell Distribution Width (RDW), and C-reactive Protein (CRP) in elderly patients with heart failure.

Methods: Convenient sampling method was used to select 98 elderly heart failure patients who visited our hospital from January 2022 to December 2020. Patients were divided into a control group and an observation group using the red and blue ball method, with 49 cases in each group.

View Article and Find Full Text PDF

Background: Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer's disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuroprotective and anti-inflammatory properties. In CBD research, PE is underutilized too.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!